AstraZeneca has said it is considering a new global trial based on the half dose first regimen. The U.S. trial calls for testing the original regimen of two full doses.from Top World News- News18.com
Read Rest:news18...
AstraZeneca has said it is considering a new global trial based on the half dose first regimen. The U.S. trial calls for testing the original regimen of two full doses.All Copyright @ Dailyhunt.website Team
SIGN UP & STAY UPDATED